SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-014931
Filing Date
2016-11-14
Accepted
2016-11-14 16:45:54
Documents
76
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1067689
2 ex31-1.htm EX-31.1 19235
3 ex31-2.htm EX-31.2 19325
4 ex32-1.htm EX-32.1 9726
  Complete submission text file 0001493152-16-014931.txt   5301922

Data Files

Seq Description Document Type Size
5 immy-20160930.xml EX-101.INS 876543
6 immy-20160930.xsd EX-101.SCH 55843
7 immy-20160930_cal.xml EX-101.CAL 84969
8 immy-20160930_def.xml EX-101.DEF 243942
9 immy-20160930_lab.xml EX-101.LAB 434868
10 immy-20160930_pre.xml EX-101.PRE 351263
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 161995569
SIC: 2834 Pharmaceutical Preparations